Joan Forns

Risk Management Solutions (United Kingdom) — United Kingdom

Environmental Science · Physical Sciences

47h-index8.2kcitations172works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Air Quality and Health Impacts(27), Health Systems, Economic Evaluations, Quality of Life(25), Health, Environment, Cognitive Aging(14), Noise Effects and Management(13), Pharmaceutical Economics and Policy(13)

Publications172 total

The Challenges for Pharmacoepidemiologists Identifying Migraine in Electronic Healthcare Data Sources: A Systematic Literature Review
Pharmacoepidemiology and Drug Safety·2025
Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases
Therapeutic Advances in Psychopharmacology·2025Open Access
Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson’s Disease Psychosis: An Update
Drug Safety·2025· 1 citedOpen Access
Plain language summary of mortality rates of patients with Parkinson’s disease psychosis who were treated either with pimavanserin or with different second-generation (atypical) antipsychotics
Future Neurology·2025Open Access
The Challenges for Pharmacoepidemiologists Identifying Migraine in Electronic Healthcare Data Sources: A Systematic Literature Review
2025
Risk of Thrombosis with Thrombocytopaenia Syndrome (Tts) after Vaccination with Azd1222: A European Vac4eu Post-Authorisation Safety Study
SSRN Electronic Journal·2025Open Access
Natural history and clinical outcomes in patients with Alzheimer's disease–related psychosis by antipsychotic treatment status in the United States
Journal of Alzheimer s Disease·2024· 1 cited
Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study
American Journal of Epidemiology·2024· 2 citedOpen Access
Mortality in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study
Drug Safety·2022· 17 citedOpen Access
Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States
BMC Geriatrics·2022· 13 citedOpen Access
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study
Neurology and Therapy·2022· 3 citedOpen Access
Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States
Research Square (Research Square)·2022Open Access
Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study
Drugs - Real World Outcomes·2021· 24 citedOpen Access
Cost transferability problems in economic evaluation as a framework for an European health care and social costs database
Cost Effectiveness and Resource Allocation·2021· 18 citedOpen Access
Walnuts, Long-Chain Polyunsaturated Fatty Acids, and Adolescent Brain Development: Protocol for the Walnuts Smart Snack Dietary Intervention Trial
Frontiers in Pediatrics·2021· 24 citedOpen Access
Increased risk of falls and fractures in patients with psychosis and Parkinson disease
PLoS ONE·2021· 15 citedOpen Access
Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies
Environmental Health Perspectives·2020· 94 citedOpen Access
Indústria farmacèutica. Innovació i solvència de l’estat del benestar
Revista econòmica de Catalunya/Revista econòmica de Catalunya·2020
Effects of prenatal exposure to particulate matter air pollution on corpus callosum and behavioral problems in children
Environmental Research·2019· 109 citedOpen Access
Antidepressant use in Denmark, Germany, Spain, and Sweden from 2009 to 2014: Incidence and comorbidities of antidepressant initiators
University of Southern Denmark Research Portal (University of Southern Denmark)·2019
page 1 of 9Next →

Frequent Co-authors

Jordi Sunyer(40), Mar Álvarez‐Pedrerol(20), Jordi Júlvez(19), Mònica Guxens(16), Raquel García‐Esteban(14), Ioar Rivas(11), Martine Vrijheid(11), Mònica López-Vicente(10), Xavier Querol(10), David Martínez(9), Mark Nieuwenhuijsen(9), Xavier Basagaña(9), Mikel Esnaola(8), Joan O. Grimalt(8), Jesús Pujol(8), Nerea Lertxundi(8), Jesús Ibarluzea(8), Mireia Gascón(7), Payam Dadvand(7), Mario Murcia(7)